What is OncoViews?
OncoViews constitutes a platform to share knowledge and treatment procedures in oncology. Our virtual initiatives leverage digital channels to provide an exceptional outreach and opportunity for healthcare professionals to interact and learn from key opinion leaders and their respective areas of expertise.
Virtual Round-Tables on Latest in Oncology
Like to learn more about the latest treatment options in Gastrointestinal, Lung, Genitourinary and Women’s Cancers after ASCO 2020? Join our interactive live webinars with leading experts discussing and sharing their views on optimal treatment procedures.
This series of OncoViews LIVE was made possible with the kind support by:
Will I be able to re-access the videos?
Yes, absolutely. The content is recorded and made available within 24 hours on our portal so that you can play it on demand as often as you like.
Does it cost me anything?
Access to the debates are completely free! Access to our round-table portal is free of charge for healthcare professionals, students, scientists or other staff from universities, hospitals & research labs as well as policy & non-profit organisations and sponsoring partners. Only registrations by non-sponsoring industry representatives are subject to a fee.
Why do you need my details for registration?
In accordance with Swiss and European regulations, we require some information about you for verification purposes to ensure that the content of our initiatives is aimed at healthcare professionals and those involved in the science, management and treatment of cancer. We will not share your personal details with any sponsor or any third party - promised!
How can I get involved in the discussion?
During the live webinar, you may submit your questions to our panel of experts and with that interact and influence the discussion.
Watch Our Virtual Round-Tables on Latest in Oncology
The virtual round-table and online content is only accessible to students of medicine and life sciences, certified healthcare professionals, associated press, industry representatives and other stakeholders in the science, management and prevention of cancer.